GORE® Cardioform ASD Occluder experience in transcatheter closure of "complex" atrial septal defects

Giuseppe Santoro1, Magdalena Cuman1, Alessandra Pizzuto1

  • 1Pediatric Cardiology and GUCH Unit, Heart Hospital "G. Pasquinucci", National Research Council-Tuscany Foundation "G. Monasterio", Massa, Italy.

Insights

The GORE® Cardioform ASD Occluder (GCO) effectively and safely closes complex atrial septal defects (ASDs) in a high percentage of patients. This transcatheter approach offers a viable solution for challenging ASD cases.

Area of Science:

  • Cardiology
  • Medical Devices
  • Interventional Cardiology

Background:

  • Transcatheter closure of atrial septal defects (ASDs) presents challenges in complex clinical and anatomical scenarios.
  • The GORE® Cardioform ASD Occluder (GCO) is a device designed for ASD closure.

Purpose of the Study:

  • To evaluate the efficacy and safety of the GORE® Cardioform ASD Occluder (GCO) for transcatheter closure of complex atrial septal defects (ASDs).

Main Methods:

  • A retrospective study involving 72 patients with significant ASDs between January 2020 and March 2021.
  • Patients were categorized into "complex" (n=36) and "simple" (n=36) ASD groups based on anatomical and clinical criteria.
  • Complex ASDs were defined by rim deficiency, large size relative to patient metrics, or multifenestrated septa.

Main Results:

  • Complex ASDs were significantly larger and associated with higher Qp/Qs ratios compared to simple ASDs.
  • Procedure and fluoroscopy times were longer for complex ASDs, with a lower procedure feasibility rate (94.4% vs. 100%) and a higher complication rate (13.9% vs. 0%).
  • Successful closure was achieved in 92% of complex ASD cases, with complete closure rates at follow-up not significantly different between groups (97.1% vs. 100%).

Conclusions:

  • Percutaneous transcatheter closure using the GCO device is an effective and safe treatment option for a high percentage of complex ASDs.
  • The GCO device demonstrates feasibility and good early outcomes in challenging ASD anatomies.
  • Despite a higher complication rate in complex cases, the overall success and closure rates are encouraging.
Abstract

Related Concept Videos

Cardiac Catheterization II: Right Heart Catheterization01:21

Cardiac Catheterization II: Right Heart Catheterization

Right Heart Catheterization: An OverviewRight heart catheterization is an invasive diagnostic procedure that measures right-sided cardiac and pulmonary artery pressures, calculates cardiac output, and identifies intracardiac shunts. It provides detailed hemodynamic data essential for diagnosing and managing various cardiovascular conditions, such as pulmonary hypertension.Access SitesCommon access sites for right heart catheterization include the internal jugular vein in the neck region, the...
241
Cardiac Catheterization III: Left Heart Catheterization01:24

Cardiac Catheterization III: Left Heart Catheterization

Left heart catheterization is an invasive diagnostic procedure used to evaluate the function and structure of the left side of the heart. It is generally performed to diagnose and treat cardiovascular conditions such as valve abnormalities, coronary artery disease, and congenital heart defects.Diagnostic and therapeutic purposesLeft heart catheterization serves various diagnostic and therapeutic purposes, including:Assessing coronary artery bypass grafts.Evaluating coronary artery disease in...
274
Aortic Regurgitation III: Medical Management01:25

Aortic Regurgitation III: Medical Management

Aortic regurgitation (AR) is when the aortic valve does not close or seal properly, leading to backward blood circulation from the aorta into the left ventricle during diastole. Common causes of AR include rheumatic heart disease, congenital valve defects, and aortic root dilation. Managing AR requires a multifaceted approach to alleviate symptoms, preserve left ventricular function, and address the underlying cause of the regurgitation. Patients with symptomatic AR or significant left...
70
Mitral Stenosis I: Introduction01:22

Mitral Stenosis I: Introduction

Mitral Valve Stenosis (MVS) is a heart condition where the mitral valve narrows, impeding blood circulation from the left atrium to the left ventricle. The etiology and pathophysiology of this condition are multifaceted, leading to a cascade of cardiovascular complications.Causes of Mitral Valve StenosisRheumatic Heart Disease: It is the main cause of mitral valve stenosis, particularly in developing nations. This condition arises from rheumatic fever, an inflammatory illness resulting from...
82
Aortic Regurgitation I: Introduction01:15

Aortic Regurgitation I: Introduction

IntroductionAortic regurgitation is characterized by the backward flow of blood from the aorta into the left ventricle during diastole and arises from the improper closure of the aortic valve. This condition results in left ventricular volume overload and can stem from both acute and chronic etiologies, each contributing uniquely to the disease's progression and symptomatology.Acute and Chronic CausesAcute aortic regurgitation often results from events that suddenly impair the integrity of the...
72